Clinical Trial Update: Transabdominal Ultrasound With BR55 for Characterization of Pancreatic Lesions [Phase 2]

View source ↗

Summary

Phase 2 study evaluating transabdominal ultrasound with BR55 to characterize pancreatic lesions in pancreatic ductal adenocarcinoma. The trial was terminated, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• BR55

Snippet

Sponsor: Bracco Diagnostics, Inc | Conditions: Pancreatic Ductal Adenocarcinoma | Phase 2 | Status: TERMINATED | Results posted: 2024-08-23